Waist Circumference Cutoff Point Determination for Defining Metabolic Syndrome in Type 2 Diabetes Mellitus in Ethiopia.
cutoff point
diabetes mellitus
metabolic syndrome
waist circumference
Journal
EJIFCC
ISSN: 1650-3414
Titre abrégé: EJIFCC
Pays: Italy
ID NLM: 101092742
Informations de publication
Date de publication:
Mar 2019
Mar 2019
Historique:
entrez:
19
3
2019
pubmed:
19
3
2019
medline:
19
3
2019
Statut:
epublish
Résumé
Metabolic syndrome (MetS) is a complex disorder characterized by a cluster of interrelated cardiovascular risk factors. So far, cutoff point variability of waist circumference was documented to define MetS. To determine the classification power and cutoff point of waist circumference to define MetS among patients with type 2 diabetes. An institution-based cross sectional study was conducted from March to April 2017 at Ayder Comprehensive Specialized Hospital among patients with type 2 diabetes. Using systematic sampling technique, 520 participants were enrolled into the study. Data were collected by checklist, anthropometric measurements and biochemical analyses. Data were entered to Epi-info 3.5.1 and transferred to SPSS 20 for analysis. Participants having more than one abnormal MetS components were categorized as patients and the others were considered as control. The classification power of waist circumference to distinguish patients from controls was determined by ROC curve analysis. Waist circumference cutoff points were determined by taking the point that had a maximum youden index. Among the 520 participants, 308 (59.2%) were females. The mean age of the participants was 56 ± 10.8 years for males and 55 ± 11.4 years for females. The classification power of waist circumference was 0.67 (0.58-0.75) for male and 0.63 (0.52-0.73) for females. The optimal waist circumference cutoff point to distinguish patients from controls were 95.5 cm (sensitivity 39.8%, specificity 86.3%, p< 0.001) for males, and 87.5 cm (sensitivity 73.1%, specificity 54.5%, p< 0.017) for females. The positive predictive value of waist circumference was 93% for females and 90% for males in Northern Ethiopia using 87.5 and 95.5 cm points cut-off for females and males, respectively.
Sections du résumé
BACKGROUND
BACKGROUND
Metabolic syndrome (MetS) is a complex disorder characterized by a cluster of interrelated cardiovascular risk factors. So far, cutoff point variability of waist circumference was documented to define MetS.
OBJECTIVE
OBJECTIVE
To determine the classification power and cutoff point of waist circumference to define MetS among patients with type 2 diabetes.
METHODS
METHODS
An institution-based cross sectional study was conducted from March to April 2017 at Ayder Comprehensive Specialized Hospital among patients with type 2 diabetes. Using systematic sampling technique, 520 participants were enrolled into the study. Data were collected by checklist, anthropometric measurements and biochemical analyses. Data were entered to Epi-info 3.5.1 and transferred to SPSS 20 for analysis. Participants having more than one abnormal MetS components were categorized as patients and the others were considered as control. The classification power of waist circumference to distinguish patients from controls was determined by ROC curve analysis. Waist circumference cutoff points were determined by taking the point that had a maximum youden index.
RESULTS
RESULTS
Among the 520 participants, 308 (59.2%) were females. The mean age of the participants was 56 ± 10.8 years for males and 55 ± 11.4 years for females. The classification power of waist circumference was 0.67 (0.58-0.75) for male and 0.63 (0.52-0.73) for females. The optimal waist circumference cutoff point to distinguish patients from controls were 95.5 cm (sensitivity 39.8%, specificity 86.3%, p< 0.001) for males, and 87.5 cm (sensitivity 73.1%, specificity 54.5%, p< 0.017) for females.
CONCLUSION
CONCLUSIONS
The positive predictive value of waist circumference was 93% for females and 90% for males in Northern Ethiopia using 87.5 and 95.5 cm points cut-off for females and males, respectively.
Types de publication
Journal Article
Langues
eng
Pagination
48-58Références
J Hum Hypertens. 2002 Feb;16(2):79-89
pubmed: 11850764
Circulation. 2004 Jan 27;109(3):433-8
pubmed: 14744958
Atherosclerosis. 2007 Jul;193(1):70-6
pubmed: 17011567
Diabetes Obes Metab. 2007 Nov;9(6):859-68
pubmed: 17924868
Am J Kidney Dis. 2008 Jul;52(1):66-73
pubmed: 18440683
N Engl J Med. 2008 Nov 13;359(20):2105-20
pubmed: 19005195
Circulation. 2009 Oct 20;120(16):1640-5
pubmed: 19805654
Diabetes Care. 2011 Apr;34(4):1032-7
pubmed: 21330644
J Family Community Med. 2010 May;17(2):73-8
pubmed: 21359028
Metab Syndr Relat Disord. 2011 Dec;9(6):491-5
pubmed: 21875336
Exp Clin Endocrinol Diabetes. 2011 Nov;119(10):599-603
pubmed: 22068551
Diabetes Care. 2013 Jun;36(6):1660-6
pubmed: 23275359
Pan Afr Med J. 2013;14:20
pubmed: 23503103
Caspian J Intern Med. 2013 Spring;4(2):627-35
pubmed: 24009950
Cardiovasc J Afr. 2014 Jan-Feb;25(1):27-33
pubmed: 24626517
J Public Health (Oxf). 2016 Mar;38(1):175-82
pubmed: 25618906
BMC Public Health. 2015 Jun 20;15:576
pubmed: 26092387
Diabetes Metab Syndr Obes. 2015 Oct 23;8:513-23
pubmed: 26604808
Indian J Endocrinol Metab. 2015 Nov-Dec;19(6):804-10
pubmed: 26693432
Int J Obes Relat Metab Disord. 1993 Apr;17(4):187-96
pubmed: 8387967